Oncolytic Virus Therapy Market : Facts, Figures and Analytical Insights 2020-2026

The Oncolytic Virus Therapy Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

According to this study, over the next five years the Oncolytic Virus Therapy market will register a 25.8% CAGR in terms of revenue, the global market size will reach $ 9 million by 2025, from $ 4 million in 2019.

Buy The Report:
https://www.marketinsightsreports.com/report/purchase/03041879838?mode=su?source=openpr&Mode=12

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Oncolytic Virus Therapy Market: Amgen, Lokon Pharma, Oncolytics Biotech, Transgene SA, Oncolys BioPharma, Viralytics, SillaJen Biotherapeutics, Targovax, Sorrento Therapeutics, PsiOxus Therapeutics, Genelux Corporation, Cold Genesys, TILT Biotherapeutics, Vyriad and others.

THOUSAND OAKS, Calif., Oct. 27, 2015 -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for IMLYGIC(TM) (talimogene laherparepvec), a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous and nodal lesions in patients with melanoma recurrent after initial surgery. IMLYGIC has not been shown to improve overall survival or have an effect on visceral metastases. IMLYGIC is the first oncolytic viral therapy approved by the FDA based on therapeutic benefit demonstrated in a pivotal study.1-3

IMLYGIC is a genetically modified herpes simplex virus type 1 designed to replicate within tumors and produce an immunostimulatory protein called granulocyte-macrophage colony-stimulating factor (GM-CSF). IMLYGIC causes cell lysis, or death, which ruptures tumors, releasing tumor-derived antigens, which along with GM-CSF, may promote an anti-tumor immune response. However, the exact mechanism of action is unknown.

SAN DIEGO and CALGARY, Alberta, April 2, 2020 -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced positive clinical data published in a peer-reviewed journal highlighting that the combination of FOLFIRI, bevacizumab and pelareorep was well tolerated, with promising efficacy signals in colorectal cancer patients with KRAS mutated tumors. The article, entitled "Elucidation of Pelareorep Pharmacodynamics in a Phase I Trial in Patients with KRAS Mutated Colorectal Cancer," authored by Dr. Sanjay Goel, Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, et al., was published on March 10, 2020, in Molecular Cancer Therapeutics.

The study enrolled 36 patients with KRAS mutation in a dose-escalation trial, of which 30 patients were assessable for response. The combination of FOLFIRI, bevacizumab and pelareorep was well tolerated, with promising signals of efficacy. Six patients received the recommended phase 2 dose (RP2D), at which a 50% overall response rate and a median overall survival (OS) of 25.1 months were observed, which compares favorably to the historical OS of 13.5 months (an 86% improvement). Among 30 evaluable patients, 6 (20%) had a partial response (PR) and 22 patients (73.3%) had stable disease (SD) as their best response, for a clinical benefit rate (PR +SD) of 93.3%.

Global Oncolytic Virus Therapy Market Split by Product Type and Applications:

This report segments the market on the basis of Types are:

HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

On the basis of Application, the market is segmented into:

Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

Click the link to get a Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/03041879838/global-oncolytic-virus-therapy-market-growth-status-and-outlook-2020-2025/inquiry?source=openpr&Mode=12

Regional Analysis For Oncolytic Virus Therapy Market:

For comprehensive understanding of market dynamics, the global Oncolytic Virus Therapy market is analyzed across key geographies namely:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Oncolytic Virus Therapy Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020-2026.

Following are major Table of Content of Oncolytic Virus Therapy Market:

- Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
- Global Market competition by top Players
- Analysis by Regions
- Consumption by Regions
- Consumption, By Types, Revenue and Market share by Types
- Consumption, By Applications, Market share (%) and Growth Rate by Applications
- Complete profiling and analysis of Players
- Industrial Chain, Sourcing Strategy and Downstream Buyers
- Marketing Strategy Analysis, Distributors/Traders
- Global Market Effect Factors Analysis
- Global Market Forecast
- Global Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter's Five Forces Analysis and SWOT Analysis.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/03041879838/global-oncolytic-virus-therapy-market-growth-status-and-outlook-2020-2025?source=openpr&Mode=12

We Offer Customization On Report Based On Specific Client Requirement:

- Free country Level analysis for any 5 countries of your choice.
- Free Competitive analysis of any 5 key market players.
- Free 40 analyst hours to cover any other data point.

Browse Related Reports:

Varicella Virus Vaccine Market:
https://www.marketinsightsreports.com/reports/05282050503/covid-19-impact-on-varicella-virus-vaccine-market-global-research-reports-2020-2021?source=openpr&Mode=12

Duck Virus Enteritis Vaccine Market:
https://www.marketinsightsreports.com/reports/05282050437/covid-19-impact-on-duck-virus-enteritis-vaccine-market-global-research-reports-2020-2021?source=openpr&Mode=12

Human Immunodeficiency Virus Testing Market:
https://www.marketinsightsreports.com/reports/05212026542/covid-19-impact-on-human-immunodeficiency-virus-testing-market-global-research-reports-2020-2021?source=openpr&Mode=12

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.